Halozyme Therapeutics (HALO) News Today $76.68 +0.87 (+1.15%) Closing price 04:00 PM EasternExtended Trading$76.75 +0.07 (+0.09%) As of 07:55 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock HALO Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 Time Period Financiere des Professionnels Fonds d investissement inc. Acquires New Position in Halozyme Therapeutics, Inc. $HALOSeptember 18 at 4:13 AM | marketbeat.comHalozyme Therapeutics, Inc. $HALO Shares Sold by Livforsakringsbolaget Skandia OmsesidigtSeptember 18 at 4:06 AM | marketbeat.comKymera Therapeutics Sees IBD RS Rating Rise To 71September 17 at 5:16 PM | msn.comWhere is Halozyme Therapeutics (HALO) Headed According to Analysts?September 17 at 3:31 PM | insidermonkey.comStrs Ohio Makes New Investment in Halozyme Therapeutics, Inc. $HALOSeptember 17 at 3:17 AM | marketbeat.comMRA Advisory Group Purchases New Shares in Halozyme Therapeutics, Inc. $HALOSeptember 16 at 6:28 AM | marketbeat.comSwedbank AB Has $16.42 Million Stock Position in Halozyme Therapeutics, Inc. $HALOSeptember 16 at 4:03 AM | marketbeat.comAshton Thomas Private Wealth LLC Purchases New Shares in Halozyme Therapeutics, Inc. $HALOSeptember 15 at 3:43 AM | marketbeat.comGoldman Sachs Group Inc. Sells 331,718 Shares of Halozyme Therapeutics, Inc. $HALOSeptember 15 at 3:42 AM | marketbeat.comFocus Partners Wealth Purchases 44,260 Shares of Halozyme Therapeutics, Inc. $HALOSeptember 15 at 3:18 AM | marketbeat.comHodges Capital Management Inc. Has $12.35 Million Stock Holdings in Halozyme Therapeutics, Inc. $HALOSeptember 14, 2025 | marketbeat.comHalozyme Therapeutics (NASDAQ:HALO) CFO Sells $1,514,200.00 in StockSeptember 13, 2025 | marketbeat.comIntech Investment Management LLC Raises Stock Position in Halozyme Therapeutics, Inc. $HALOSeptember 13, 2025 | marketbeat.com8,083 Shares in Halozyme Therapeutics, Inc. $HALO Acquired by Fred Alger Management LLCSeptember 13, 2025 | marketbeat.comInsider Selling: Halozyme Therapeutics (NASDAQ:HALO) CFO Sells 20,000 Shares of StockSeptember 12, 2025 | insidertrades.comUnited Services Automobile Association Acquires New Shares in Halozyme Therapeutics, Inc. $HALOSeptember 12, 2025 | marketbeat.comGreat Lakes Advisors LLC Buys 98,190 Shares of Halozyme Therapeutics, Inc. $HALOSeptember 11, 2025 | marketbeat.comDoes Halozyme Stock Offer More Potential After Its Recent Strong Price Run in 2025?September 11, 2025 | uk.finance.yahoo.comHalozyme Therapeutics (NASDAQ:HALO) Sets New 52-Week High - Should You Buy?September 10, 2025 | marketbeat.comRedwood Investments LLC Purchases 8,146 Shares of Halozyme Therapeutics, Inc. $HALOSeptember 10, 2025 | marketbeat.comTeza Capital Management LLC Acquires Shares of 8,976 Halozyme Therapeutics, Inc. $HALOSeptember 10, 2025 | marketbeat.comJacobs Levy Equity Management Inc. Acquires Shares of 182,354 Halozyme Therapeutics, Inc. $HALOSeptember 10, 2025 | marketbeat.comAxsome Therapeutics Stock Sees RS Rating Rise To 82September 9, 2025 | msn.comDianthus Therapeutics Stock Earns RS Rating UpgradeSeptember 8, 2025 | msn.comHalozyme Therapeutics, Inc. (HALO) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference TranscriptSeptember 8, 2025 | seekingalpha.comHalozyme Therapeutics, Inc. $HALO is Panoramic Capital LLC's 3rd Largest PositionSeptember 8, 2025 | marketbeat.comHalozyme Therapeutics, Inc. $HALO Shares Purchased by Clark Capital Management Group Inc.September 7, 2025 | marketbeat.comHalozyme Therapeutics (NASDAQ:HALO) Downgraded to "Buy" Rating by Wall Street ZenSeptember 7, 2025 | americanbankingnews.comHancock Whitney Corp Acquires 83,007 Shares of Halozyme Therapeutics, Inc. $HALOSeptember 6, 2025 | marketbeat.comEFG Asset Management North America Corp. Cuts Stock Holdings in Halozyme Therapeutics, Inc. $HALOSeptember 6, 2025 | marketbeat.comCutter Capital Management LP Invests $7.66 Million in Halozyme Therapeutics, Inc. $HALOSeptember 6, 2025 | marketbeat.comHalozyme Therapeutics, Inc. $HALO Shares Acquired by Alliancebernstein L.P.September 6, 2025 | marketbeat.comZacks Research Issues Positive Estimate for HALO EarningsSeptember 6, 2025 | marketbeat.comHalozyme Therapeutics (NASDAQ:HALO) Upgraded to Strong-Buy at Zacks ResearchSeptember 6, 2025 | marketbeat.comHsbc Holdings PLC Sells 4,961 Shares of Halozyme Therapeutics, Inc. $HALOSeptember 6, 2025 | marketbeat.comZacks.com featured highlights include Halozyme Therapeutics, Phibro, Leidos and PDD HoldingsSeptember 5, 2025 | finance.yahoo.comHelen Torley Sells 20,000 Shares of Halozyme Therapeutics (NASDAQ:HALO) StockSeptember 5, 2025 | insidertrades.comHalozyme Therapeutics, Inc. $HALO Shares Acquired by The Manufacturers Life Insurance CompanySeptember 5, 2025 | marketbeat.comCanada Pension Plan Investment Board Trims Stake in Halozyme Therapeutics, Inc. $HALOSeptember 5, 2025 | marketbeat.comHow to Find Strong Buy Medical Stocks Using the Zacks RankSeptember 4, 2025 | uk.finance.yahoo.comHalozyme Therapeutics (NASDAQ:HALO) Director Sells $294,720.00 in StockSeptember 4, 2025 | marketbeat.comHalozyme Therapeutics, Inc. (HALO) Presents At Wells Fargo 20th Annual Healthcare Conference 2025 Prepared Remarks TranscriptSeptember 4, 2025 | seekingalpha.comHalozyme Therapeutics (NASDAQ:HALO) Hits New 52-Week High - Here's What HappenedSeptember 4, 2025 | marketbeat.comPDT Partners LLC Grows Position in Halozyme Therapeutics, Inc. $HALOSeptember 3, 2025 | marketbeat.comPinnacle Wealth Planning Services Inc. Takes Position in Halozyme Therapeutics, Inc. $HALOSeptember 3, 2025 | marketbeat.comBernadette Connaughton Sells 4,000 Shares of Halozyme Therapeutics (NASDAQ:HALO) StockSeptember 3, 2025 | insidertrades.comSteamboat Capital Partners LLC Has $9.57 Million Position in Halozyme Therapeutics, Inc. $HALOSeptember 2, 2025 | marketbeat.comWellington Management Group LLP Decreases Stock Holdings in Halozyme Therapeutics, Inc. $HALOSeptember 1, 2025 | marketbeat.comRafferty Asset Management LLC Sells 106,103 Shares of Halozyme Therapeutics, Inc. $HALOAugust 30, 2025 | marketbeat.comHalozyme Therapeutics, Inc. (HALO) Hikes 2025 Guidance on ENHANZE DemandAugust 29, 2025 | finance.yahoo.com Get Halozyme Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for HALO and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. HALO Media Mentions By Week HALO Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. HALO News Sentiment▼1.370.63▲Average Medical News Sentiment HALO News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. HALO Articles This Week▼1714▲HALO Articles Average Week Get the Latest News and Ratings for HALO and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Halozyme Therapeutics and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies BIIB News Today UTHR News Today INCY News Today NBIX News Today EXEL News Today BMRN News Today EXAS News Today IONS News Today MDGL News Today RGEN News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:HALO) was last updated on 9/18/2025 by MarketBeat.com Staff From Our PartnersGold surges past $3,600 … but this has beat gold by 1,000xGold has surged past $3,600 an ounce — up 45% in the past year — but one veteran metals analyst says the real ...Weiss Ratings | SponsoredREVEALED: Something Big Happening Behind White House Doorswhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredCrypto Gets Official Government Backing—Here's the WinnerTrump Just Signed the GENIUS Act—One Coin is About to Explode We're at the BEGINNING of smart money really ...Crypto 101 Media | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredAlert: Prepare for Trump's Dollar OverhaulPresident Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking a...Brownstone Research | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Halozyme Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Halozyme Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
